Alteration of 8-hydroxyguanosine concentrations in the cerebrospinal fluid and serum from patients with Parkinson's disease (Q44260283)

1 December 2017

Alteration of 8-hydroxyguanosine concentrations in the cerebrospinal fluid and serum from patients with Parkinson's disease (English)

1 reference

1 December 2017

0 references

0 references

1 reference

Takashi Abe

1

1 reference

1 December 2017

Chiaki Isobe

2

1 reference

1 December 2017

Takahiko Murata

3

1 reference

1 December 2017

Chigumi Sato

4

1 reference

1 December 2017

Hideo Tohgi

5

1 reference

1 December 2017

language of work or name

English

0 references

publication date

1 January 2003

1 reference

1 December 2017

1 reference

1 December 2017

336

1 reference

1 December 2017

2

1 reference

1 December 2017

105-108

1 reference

Oxidative DNA damage in the parkinsonian brain: an apparent selective increase in 8-hydroxyguanine levels in substantia nigra.

1 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901259-4

7 January 2021

Aging, energy, and oxidative stress in neurodegenerative diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901259-4

7 January 2021

Indices of oxidative stress and mitochondrial function in individuals with incidental Lewy body disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901259-4

7 January 2021

Increased nigral iron content and alterations in other metal ions occurring in brain in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901259-4

7 January 2021

Antioxidants, oxidative stress, and degenerative neurological disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901259-4

7 January 2021

Aging: a theory based on free radical and radiation chemistry

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901259-4

7 January 2021

Why are nigral catecholaminergic neurons more vulnerable than other cells in Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901259-4

7 January 2021

Aberrant RNA processing in a neurodegenerative disease: the cause for absent EAAT2, a glutamate transporter, in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901259-4

7 January 2021

Toxic and protective effects of L-dopa on mesencephalic cell cultures

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901259-4

7 January 2021

Oxidative damage is the earliest event in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901259-4

7 January 2021

Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901259-4

7 January 2021

RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901259-4

7 January 2021

RNA Oxidation in Alzheimer and Parkinson Diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901259-4

7 January 2021

Parkinson's disease: a disorder due to nigral glutathione deficiency?

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901259-4

7 January 2021

Oxidative base damage in RNA detected by reverse transcriptase

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901259-4

7 January 2021

In situ methods for detection and localization of markers of oxidative stress: application in neurodegenerative disorders.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901259-4

7 January 2021

Urinary 8-hydroxy-2'-deoxyguanosine as a biological marker of in vivo oxidative DNA damage

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901259-4

7 January 2021

Counteraction by MutT protein of transcriptional errors caused by oxidative damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901259-4

7 January 2021

Frameshift mutants of beta amyloid precursor protein and ubiquitin-B in Alzheimer's and Down patients

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901259-4

7 January 2021

Oxidative damage to nucleic acids photosensitized by titanium dioxide

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901259-4

7 January 2021

Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901259-4

7 January 2021

Parkinson's disease is associated with oxidative damage to cytoplasmic DNA and RNA in substantia nigra neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2901259-4

7 January 2021

10.1016/S0304-3940(02)01259-4

Identifiers

DOI

1 reference

1 December 2017

1 reference